Evommune Inc (EVMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -68,870 | -66,808 |
| Depreciation Amortization | 1,389 | 1,287 |
| Accounts payable and accrued liabilities | -837 | 6,506 |
| Other Working Capital | -4,119 | 7,424 |
| Other Operating Activity | -4,004 | -6,604 |
| Operating Cash Flow | $-76,441 | $-58,195 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -115,072 | -3,905 |
| PPE Investments | -235 | -88 |
| Investing Cash Flow | $-115,307 | $-3,993 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -531 | -423 |
| Common Stock Issued | 6 | 13 |
| Other Financing Activity | 221,288 | 49,829 |
| Financing Cash Flow | $220,763 | $49,419 |
| Beginning Cash Position | 16,463 | 29,232 |
| End Cash Position | 45,478 | 16,463 |
| Net Cash Flow | $29,015 | $-12,769 |
| Free Cash Flow | ||
| Operating Cash Flow | -76,441 | -58,195 |
| Capital Expenditure | -235 | -88 |
| Free Cash Flow | -76,676 | -58,283 |